COVID-19 Update:Learn more about how we are protecting our patients, families and staff, as well as other important facts about COVID-19.
Business Wire Covered White Matter Disorder Study Led by Children's Expert
May 09, 2016
Whole exome sequencing (WES), a method looking at all genes in the genome at once, yielded clinical diagnoses for 42 percent of patients whose white matter abnormalities had been unresolved an average of eight years, ending families' "prolonged diagnostic odyssey," according to an international study team that included lead author, Adeline Vanderver, M.D., Center for Neuroscience and Behavioral Medicine.
Read the full article here.